Metabolon
PrivateLast Round
Debt
May 16, 2024
Total Funding Raised
$160.79M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Metabolon operates in Healthcare & Life Sciences and is based in Morrisville, North Carolina. Its latest recorded funding round was a Debt round in May 2024.
Metabolon is a biotechnology company that develops proprietary analytical methods and software for biomarker discovery using metabolomics to provide biological insights for life sciences research and drug development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Metabolon Comparables
Compare Metabolon with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Metware Biotechnology | 83% | |
| Creative Proteomics | 83% | |
| Sapient | 82% |
For institutional investors. Book with your work email.
Metabolon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 16, 2024 | ||||
| VC Round | Jan 24, 2023 | ||||
| VC Round | Sep 23, 2020 | ||||
| Grant | Apr 8, 2020 | ||||
| Debt | Oct 11, 2018 | ||||
Series E | Aug 17, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Metabolon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Trelys Funds | Series B, Series A |
| Innovatus Capital Partners | Debt |
| Fulcrum Financial Services | Series D, Series E, Series C |
| Perceptive Advisors | VC Round |
| EW Healthcare Partners | VC Round, Series F |
| Fletcher Spaght | Series D, Series C |
| Fletcher Spaght Ventures | Series D, Series E, Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 42% MoM, reaching 40.2K.
- Jun 22, 2026
Launched the Verus Metabolomics Profiling Kit and Integrated Bioinformatics Platform.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesOct 20, 2026
Metabolon announces Splash & Ripple, a bioinformatics application that helps researchers translate metabolomic biomarkers into candidate protein mechanisms and actionable multiomic hypotheses, in North Carolina on Oct 20th '26.
- launchesOct 20, 2026
Metabolon announces Splash & Ripple, a bioinformatics application that helps researchers translate metabolomic biomarkers into candidate protein mechanisms and actionable multiomic hypotheses, in North Carolina on Oct 20th '26.
For institutional investors. Book with your work email.
Metabolon Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Metabolon's valuation, stock price, and market status.
Is Metabolon a public or private company?
Metabolon is a private company.
What is the current stock price of Metabolon?
Metabolon is a private company, so its shares have no public market price. Caplight tracks Metabolon's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Metabolon worth (valuation)?
Valuation information for Metabolon is not publicly available.
Can I buy Metabolon stock?
Metabolon shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Metabolon's last funding round?
Metabolon's most recent funding round was Debt on May 16, 2024.
Who are the main investors in Metabolon?
Key investors in Metabolon include EW Healthcare Partners, Fletcher Spaght, Fulcrum Financial Group, Crossroads Liquidating Trust, 180 Degree Capital Corp..
Will Metabolon IPO soon?
No public IPO plans have been announced for Metabolon.
How can I track Metabolon secondary market activity?
Caplight tracks bids, offers, and trades in Metabolon's shares on secondary markets.